FDA Inspection
Redox S.r.l.Redox S.r.l. – FDA Inspection, Feb 20, 2015
Record Details
This FDA Inspection record concerns Redox S.r.l., with an inspection on February 20, 2015, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Redox S.r.l.
- Inspection Date
- February 20, 2015
- Product Type
- Drugs
View Company Profile
ID · 7adebe31-c39f-4128-9ff1-b09eefa5b77c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 917270
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Redox S.r.l.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 8, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 24, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 12, 2019 | Not classified | Office of Inspections and Investigations | |
| September 28, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Redox S.r.l.
- FDA Inspection 1269520 - 2023-03-08
- FDA Inspection 1119645 - 2019-05-24
- FDA Inspection 1090329 - 2019-04-12
- FDA Inspection 747478 - 2011-09-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.